查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1659413

全球分子生物學酵素、套件和試劑市場

Molecular Biology Enzymes and Kits & Reagents
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 89 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球分子生物學酵素、套件和試劑市場規模將達到 705 億美元

2024 年全球分子生物學酶、套件和試劑市場規模估計為 324 億美元，預計到 2030 年將達到 705 億美元，2024-2030 年分析期內的複合年成長率為 13.9%。分子生物學套件和試劑是報告分析的細分市場之一，預計複合年成長率為 14.6%，到分析期結束時將達到 648 億美元。在分析期內，分子生物學酶部分預計將以 7.0% 的複合年成長率成長。

美國市場規模估計為 90 億美元，中國市場預估年複合成長率為 13.2%

預計2024年美國分子生物學酵素、套件和試劑市場規模將達 90 億美元。中國作為世界第二大經濟體，預計到 2030 年市場規模將達到 108 億美元，2024 年至 2030 年的複合年成長率為 13.2%。其他值得注意的區域市場包括日本和加拿大，預計在分析期間的複合年成長率分別為 12.0% 和 11.5%。在歐洲，德國的複合年成長率預計約為 9.5%。

全球分子生物學酶、套件和試劑市場 - 主要趨勢和促進因素摘要

分子生物學酵素、套件和試劑如何徹底改變研究？

分子生物學酵素、套件和試劑是各種研究應用中使用的必不可少的工具，包括 DNA序列測定、聚合酵素鏈鎖反應(PCR)、基因克隆和蛋白質分析。這些產品在生命科學、生物技術和藥物研究中發揮重要作用，使科學家能夠研究遺傳物質的結構、功能和相互作用。分子生物學酶，例如 DNA聚合酵素、限制性酶和連接酶，有助於操作和分析核酸，對於了解疾病、開發新治療方法和推進基因工程至關重要。由於基因組學、蛋白質組學和個人化醫療研究活動的增加，分子生物學酶、套件和試劑的市場正在擴大。人們對遺傳疾病的了解和開發標靶治療的關注度不斷提高，推動了對先進分子生物學工具的需求。製藥公司和研究機構正在大力投資分子生物學研究，以加速藥物發現並改善診斷技術，進一步推動市場成長。

哪些趨勢推動了分子生物學酵素、套件和試劑市場的發展？

影響分子生物學酶、套件和試劑市場的主要趨勢包括次世代定序儀(NGS) 的興起、生物技術和生命科學研究的成長以及對個人化醫療的日益關注。 NGS技術透過實現DNA序列的高通量分析徹底改變了基因組研究，推動了對分子生物學酶和試劑的需求。 NGS 平台和技術的快速進步為公司開發針對定序應用的專用酵素和套件創造了機會。人們越來越重視個人化醫療，即根據個人基因組成客製化治療方案，這也推動了對分子生物學工具的需求。研發部門正在使用這些工具來研究基因突變並開發精準治療方法。此外，生物技術產業的擴張導致研發資金的增加，從而增加了對高品質分子生物學產品的需求，這也促進了市場的發展。

市場區隔將如何影響分子生物學酵素、套件和試劑？

產品類型包括酵素、套件和試劑，其中酵素佔最大佔有率，因為其廣泛應用於各種分子生物學技術。這些產品具有廣泛的應用範圍，包括研究、診斷和治療開發，主要使用者是實驗室和學術機構。最終用戶部門包括學術和研究機構、醫院和診斷中心以及製藥和生物技術公司。由於對藥物研發的投資不斷增加，製藥和生技產業正在經歷顯著的成長。從地區來看，北美憑藉先進的研究基礎設施和大量生命科學資金佔據市場主導地位。同時，由於研究活動的增加和政府對生物技術發展的支持，亞太地區正在經歷快速成長。

哪些因素推動了分子生物學酵素、套件和試劑市場的成長？

分子生物學酶、套件和試劑市場的成長受到多種因素的推動，包括對基因研究的需求不斷增加、分子生物學技術的進步以及對個人化醫療的日益關注。基因組學和蛋白​​質組學研究的擴展正在推動對分子生物學工具的需求。 NGS 和其他分子技術的發展為開發專門產品創造了機會。此外，精準醫療的成長趨勢正在推動分子生物學酶、套件和試劑在標靶治療和診斷方面的發展。

部分

產品（套件和試劑、酵素）；應用（PCR、定序、克隆、表觀遺傳學、其他應用）；最終用途（學術和研究、製藥和生物技術、醫院和診斷、其他最終用途）

受訪公司範例（值得關注的33家公司）

  • Affymetrix, Inc.
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Enzymatics
  • F. Hoffmann-La Roche Ltd.
  • Illumina, Inc.
  • LGC Limited
  • Merck KGaA
  • New England Biolabs
  • Promega Corporation
  • QIAGEN
  • Sigma-Aldrich Co. LLC
  • Takara Bio, Inc.
  • Thermo Fisher Scientific, Inc.

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他地區

第4章 競賽

簡介目錄
Product Code: MCP22322

Global Molecular Biology Enzymes and Kits & Reagents Market to Reach US$70.5 Billion by 2030

The global market for Molecular Biology Enzymes and Kits & Reagents estimated at US$32.4 Billion in the year 2024, is expected to reach US$70.5 Billion by 2030, growing at a CAGR of 13.9% over the analysis period 2024-2030. Molecular Biology Kits & Reagents, one of the segments analyzed in the report, is expected to record a 14.6% CAGR and reach US$64.8 Billion by the end of the analysis period. Growth in the Molecular Biology Enzymes segment is estimated at 7.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$9.0 Billion While China is Forecast to Grow at 13.2% CAGR

The Molecular Biology Enzymes and Kits & Reagents market in the U.S. is estimated at US$9.0 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$10.8 Billion by the year 2030 trailing a CAGR of 13.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 12.0% and 11.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 9.5% CAGR.

Global Molecular Biology Enzymes and Kits & Reagents Market - Key Trends and Drivers Summarized

How Are Molecular Biology Enzymes, Kits & Reagents Revolutionizing Research?

Molecular biology enzymes, kits, and reagents are essential tools used in various research applications, including DNA sequencing, polymerase chain reactions (PCR), gene cloning, and protein analysis. These products play a critical role in life sciences, biotechnology, and pharmaceutical research, enabling scientists to study the structure, function, and interactions of genetic material. Molecular biology enzymes, such as DNA polymerases, restriction enzymes, and ligases, facilitate the manipulation and analysis of nucleic acids, which is crucial for understanding diseases, developing new treatments, and advancing genetic engineering. The market for molecular biology enzymes, kits, and reagents is expanding due to increasing research activities in genomics, proteomics, and personalized medicine. With the growing focus on understanding genetic disorders and developing targeted therapies, there is a rising demand for advanced molecular biology tools. Pharmaceutical companies and research institutions are investing heavily in molecular biology research to accelerate drug discovery and improve diagnostic techniques, further fueling the market's growth.

What Trends Are Driving the Molecular Biology Enzymes, Kits & Reagents Market?

Key trends influencing the molecular biology enzymes, kits, and reagents market include the rise of next-generation sequencing (NGS), the growth of biotechnology and life sciences research, and the increasing focus on personalized medicine. NGS technologies have revolutionized genomics research by enabling high-throughput analysis of DNA sequences, driving the demand for molecular biology enzymes and reagents. The rapid advancements in NGS platforms and techniques are creating opportunities for companies to develop specialized enzymes and kits tailored for sequencing applications. The growing emphasis on personalized medicine, which involves tailoring medical treatments based on an individual's genetic makeup, is also boosting the demand for molecular biology tools. Researchers are using these tools to study genetic variations and develop precision therapies. Additionally, the expansion of the biotechnology industry, with increased funding for research and development, is further contributing to market growth by driving demand for high-quality molecular biology products.

How Do Market Segments Impact Molecular Biology Enzymes, Kits & Reagents?

Product categories include enzymes, kits, and reagents, with enzymes accounting for the largest share due to their extensive use in various molecular biology techniques. Applications of these products span across research, diagnostics, and therapeutic development, with research laboratories and academic institutions being the primary users. The end-user segment includes academic and research institutes, hospitals and diagnostic centers, and pharmaceutical and biotechnology companies. The pharmaceutical and biotechnology segment is witnessing significant growth due to increasing investments in drug discovery and development. Geographically, North America dominates the market due to advanced research infrastructure and substantial funding for life sciences. Meanwhile, the Asia-Pacific region is experiencing rapid growth, driven by increasing research activities and government support for biotechnology development.

What Factors Are Driving the Growth in the Molecular Biology Enzymes, Kits & Reagents Market?

The growth in the molecular biology enzymes, kits, and reagents market is driven by several factors, including the rising demand for genetic research, advancements in molecular biology techniques, and the increasing focus on personalized medicine. The expansion of genomics and proteomics research is boosting the demand for molecular biology tools. Advancements in NGS and other molecular techniques are creating opportunities for the development of specialized products. Furthermore, the growing trend of precision medicine is encouraging the use of molecular biology enzymes, kits, and reagents for the development of targeted therapies and diagnostics.

SCOPE OF STUDY:

The report analyzes the Molecular Biology Enzymes and Kits & Reagents market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Kits & Reagents, Enzymes); Application (PCR, Sequencing, Cloning, Epigenetics, Other Applications); End-Use (Academic & Research, Pharma & Biotech, Hospital & Diagnostics, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 33 Featured) -

  • Affymetrix, Inc.
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Enzymatics
  • F. Hoffmann-La Roche Ltd.
  • Illumina, Inc.
  • LGC Limited
  • Merck KGaA
  • New England Biolabs
  • Promega Corporation
  • QIAGEN
  • Sigma-Aldrich Co. LLC
  • Takara Bio, Inc.
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Molecular Biology Enzymes and Kits & Reagents - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Genomics and Proteomics Research Spurs Growth in Molecular Biology Enzymes and Kits & Reagents Market
    • Technological Advancements in High-Fidelity Enzymes and PCR Kits Strengthen Business Case for Adoption
    • Growing Focus on Personalized Medicine and Diagnostic Applications Expands Addressable Market
    • Expansion of Molecular Biology Enzymes and Kits in Pharmaceutical and Biotechnology Industries Fuels Market Growth
    • Increasing Adoption of NGS (Next-Generation Sequencing) and CRISPR Technologies Expands Market Opportunities
    • Technological Innovations in Recombinant Enzymes and High-Throughput Kits Propel Market Expansion
    • Rising Focus on Enhancing Accuracy and Reproducibility in Molecular Experiments Drives Demand for Enzymes and Kits
    • Growing Use of Molecular Biology Enzymes and Kits in Agriculture and Food Safety Testing Expands Market Potential
    • Focus on Reducing Experiment Time and Improving Workflow Efficiency Strengthens Market for Molecular Biology Reagents
    • Rising Adoption of Molecular Biology Enzymes in Cancer Research and Biomarker Discovery Expands Addressable Market
    • Technological Advancements in Point-of-Care Molecular Diagnostic Kits Propel Market Growth
    • Expansion of Molecular Biology Reagents in Environmental and Microbial Studies Expands Market Opportunities
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Molecular Biology Enzymes and Kits & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Kits & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Kits & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Kits & Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Enzymes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Enzymes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Enzymes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Academic & Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Academic & Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Academic & Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Hospital & Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Hospital & Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Hospital & Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Pharma & Biotech by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Pharma & Biotech by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 21: World 15-Year Perspective for Pharma & Biotech by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 24: World 15-Year Perspective for Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for PCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 26: World Historic Review for PCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 27: World 15-Year Perspective for PCR by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Cloning by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 29: World Historic Review for Cloning by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 30: World 15-Year Perspective for Cloning by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 31: World Recent Past, Current & Future Analysis for Epigenetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 32: World Historic Review for Epigenetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 33: World 15-Year Perspective for Epigenetics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 34: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 35: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 36: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 37: World Molecular Biology Enzymes and Kits & Reagents Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Molecular Biology Enzymes and Kits & Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 38: USA Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Product - Percentage Breakdown of Value Sales for Kits & Reagents and Enzymes for the Years 2015, 2025 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by End-Use - Percentage Breakdown of Value Sales for Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech for the Years 2015, 2025 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: USA 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Application - Percentage Breakdown of Value Sales for PCR, Sequencing, Cloning, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Product - Percentage Breakdown of Value Sales for Kits & Reagents and Enzymes for the Years 2015, 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by End-Use - Percentage Breakdown of Value Sales for Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech for the Years 2015, 2025 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Canada 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Application - Percentage Breakdown of Value Sales for PCR, Sequencing, Cloning, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
  • JAPAN
    • Molecular Biology Enzymes and Kits & Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Product - Percentage Breakdown of Value Sales for Kits & Reagents and Enzymes for the Years 2015, 2025 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by End-Use - Percentage Breakdown of Value Sales for Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech for the Years 2015, 2025 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Japan 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Application - Percentage Breakdown of Value Sales for PCR, Sequencing, Cloning, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
  • CHINA
    • Molecular Biology Enzymes and Kits & Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 65: China Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Product - Percentage Breakdown of Value Sales for Kits & Reagents and Enzymes for the Years 2015, 2025 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: China 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by End-Use - Percentage Breakdown of Value Sales for Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech for the Years 2015, 2025 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: China 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Application - Percentage Breakdown of Value Sales for PCR, Sequencing, Cloning, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
  • EUROPE
    • Molecular Biology Enzymes and Kits & Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Molecular Biology Enzymes and Kits & Reagents by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Product - Percentage Breakdown of Value Sales for Kits & Reagents and Enzymes for the Years 2015, 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Europe 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by End-Use - Percentage Breakdown of Value Sales for Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech for the Years 2015, 2025 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Europe 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Application - Percentage Breakdown of Value Sales for PCR, Sequencing, Cloning, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
  • FRANCE
    • Molecular Biology Enzymes and Kits & Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 86: France Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: France 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Product - Percentage Breakdown of Value Sales for Kits & Reagents and Enzymes for the Years 2015, 2025 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: France 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by End-Use - Percentage Breakdown of Value Sales for Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech for the Years 2015, 2025 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: France 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Application - Percentage Breakdown of Value Sales for PCR, Sequencing, Cloning, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
  • GERMANY
    • Molecular Biology Enzymes and Kits & Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Germany 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Product - Percentage Breakdown of Value Sales for Kits & Reagents and Enzymes for the Years 2015, 2025 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Germany 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by End-Use - Percentage Breakdown of Value Sales for Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech for the Years 2015, 2025 & 2030
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Germany 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Application - Percentage Breakdown of Value Sales for PCR, Sequencing, Cloning, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Italy 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Product - Percentage Breakdown of Value Sales for Kits & Reagents and Enzymes for the Years 2015, 2025 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Italy 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by End-Use - Percentage Breakdown of Value Sales for Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech for the Years 2015, 2025 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Italy 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Application - Percentage Breakdown of Value Sales for PCR, Sequencing, Cloning, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Molecular Biology Enzymes and Kits & Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 113: UK Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: UK 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Product - Percentage Breakdown of Value Sales for Kits & Reagents and Enzymes for the Years 2015, 2025 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: UK 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by End-Use - Percentage Breakdown of Value Sales for Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech for the Years 2015, 2025 & 2030
    • TABLE 119: UK Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: UK 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Application - Percentage Breakdown of Value Sales for PCR, Sequencing, Cloning, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 122: Rest of Europe Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Europe Historic Review for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Rest of Europe 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Product - Percentage Breakdown of Value Sales for Kits & Reagents and Enzymes for the Years 2015, 2025 & 2030
    • TABLE 125: Rest of Europe Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Europe Historic Review for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Europe 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by End-Use - Percentage Breakdown of Value Sales for Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech for the Years 2015, 2025 & 2030
    • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Europe Historic Review for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Europe 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Application - Percentage Breakdown of Value Sales for PCR, Sequencing, Cloning, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Molecular Biology Enzymes and Kits & Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 131: Asia-Pacific Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Asia-Pacific Historic Review for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Asia-Pacific 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Product - Percentage Breakdown of Value Sales for Kits & Reagents and Enzymes for the Years 2015, 2025 & 2030
    • TABLE 134: Asia-Pacific Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Asia-Pacific Historic Review for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Asia-Pacific 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by End-Use - Percentage Breakdown of Value Sales for Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech for the Years 2015, 2025 & 2030
    • TABLE 137: Asia-Pacific Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Asia-Pacific Historic Review for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Asia-Pacific 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Application - Percentage Breakdown of Value Sales for PCR, Sequencing, Cloning, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 140: Rest of World Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of World Historic Review for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of World 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Product - Percentage Breakdown of Value Sales for Kits & Reagents and Enzymes for the Years 2015, 2025 & 2030
    • TABLE 143: Rest of World Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of World Historic Review for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Rest of World 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by End-Use - Percentage Breakdown of Value Sales for Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech for the Years 2015, 2025 & 2030
    • TABLE 146: Rest of World Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of World Historic Review for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Rest of World 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Application - Percentage Breakdown of Value Sales for PCR, Sequencing, Cloning, Epigenetics and Other Applications for the Years 2015, 2025 & 2030

IV. COMPETITION